Picture of Cyclo Therapeutics logo

CYTH — Cyclo Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapMomentum Trap

Cyclo Therapeutics Inc expected to post a loss of 44 cents a share - Earnings Preview

* Cyclo Therapeutics Inc  CYTH.OQ   CYTH.O  is expected
to show a
fall in quarterly revenue when it reports  results on August 14
(estimated). 
    * The Gainesville Florida Florida-based  company is expected
to
report  a 26.8% decrease in revenue to $396 thousand from $541
thousand a year ago, according to the estimate from one analyst,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Cyclo Therapeutics
Inc is
for a loss of 44 cents per share. 
    * The one available analyst rating on the shares is
"hold".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​

This summary was machine generated August 12 at 01:03 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Cyclo Therapeutics

See all news